# Tenaya Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Feb 26, 2026

- Company: [Tenaya Therapeutics, Inc.](/companies/tnya.md) (CIK 1858848)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-26
- Accepted by EDGAR: Feb 26, 2026, 16:29 ET
- Period: not reported
- Accession: 0001193125-26-076892
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1858848/000119312526076892/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1858848/000119312526076892/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1858848/000119312526076892/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-076892. Last ingested by Listed: Nov 4, 2026, 17:31 ET. No prices; not investment advice.